Abstract
The biology and properties of dendritic cells (DCs) have been intensely studied in the research areas of infectious diseases, tumor immunology, and vaccine development. This unique subset of immune cells has recently also moved to the center of interest for basic and clinical research in autoimmunity, owing not only to the extraordinary importance of DCs in the initiation and sustenance of adaptive immune responses, but also to more recent discoveries about their profound ability to control and downregulate ongoing T-cell responses. We review current progress of using DCs in mice for induction and propagation of autoimmune T-cell responses and their therapeutic potential to dampen or even stop β-cell-specific autoimmunity. Finally, we offer our perspective on how basic research progress in DC technology, mostly from mouse models, may translate into emerging diagnostic and therapeutic applications for human type 1 diabetes.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References and Recommended Reading
Tang Q, Bluestone JA: Regulatory T-cell physiology and application to treat autoimmunity. Immunol Rev 2006, 212:217–237.
Iruretagoyena MI, Wiesendanger M, Kalergis AM: The dendritic cell-T cell synapse as a determinant of autoimmune pathogenesis. Curr Pharm Des 2006, 12:131–147.
Manuel SL, Rahman S, Wigdahl B, et al.: Dendritic cells in autoimmune diseases and neuroinflammatory disorders. Front Biosci 2007, 12:4315–4335.
Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 2001, 358:221–229.
Imagawa A, Hanafusa T, Itoh N, et al.: Immunological abnormalities in islets at diagnosis paralleled further deterioration of glycaemic control in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1999, 42:574–578.
Jansen A, Homo-Delarche F, Hooijkaas H, et al.: Immunohistochemical characterization of monocytes-macrophages and dendritic cells involved in the initiation of the insulitis and beta-cell destruction in NOD mice. Diabetes 1994, 43:667–675.
Charre S, Rosmalen JG, Pelegri C, et al.: Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 2002, 17:393–401.
Nikolic T, Geutskens SB, van Rooijen N, et al.: Dendritic cells and macrophages are essential for the retention of lymphocytes in (peri)-insulitis of the nonobese diabetic mouse: a phagocyte depletion study. Lab Invest 2005, 85:487–501.
Green EA, Eynon EE, Flavell RA: Local expression of TNF-alpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. Immunity 1998, 9:733–743.
Dahlen E, Dawe K, Ohlsson L, Hedlung G: Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 1998, 160:3585–3593.
Morel PA, Vasquez AC, Feili-Hariri M: Immunobiology of DC in NOD mice. J Leukoc Biol 1999, 66:276–280.
Yoon JW, Jun HS: Autoimmune destruction of pancreatic beta cells. Am J Ther 2005, 12:580–591.
Tang Q, Adams JY, Tooley AJ, et al.: Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat Immunol 2006, 7:83–92.
Marleau AM, Singh B: Myeloid dendritic cells in non-obese diabetic mice have elevated costimulatory and T helper-1-inducing abilities. J Autoimmun 2002, 19:23–35.
Weaver DJ, Jr, Poligone B, Bui T, et al.: Dendritic cells from nonobese diabetic mice exhibit a defect in NF-kappaB regulation due to a hyperactive I kappa B kinase. J Immunol 2001, 167:1461–1468.
Wheat W, Kupfer R, Gutches DG, et al.: Increased NF-kappaB activity in B cells and bone marrow-derived dendritic cells from NOD mice. Eur J Immunol 2004, 34:1395–1404.
Boudaly S, Morin J, Berthier R, et al.: Altered DCs (DC) might be responsible for regulatory T cell imbalance and autoimmunity in nonobese diabetic (NOD) mice. Eur Cytokine Netw 2002, 13:29–37.
Strid J, Lopes L, Marcinkiewicz J, et al.: A defect in bone marrow derived dendritic cell maturation in the nonobese diabetic mouse. Clin Exp Immunol 2001, 123:375–381.
Peng R, Li Y, Brezner K, et al.: Abnormal peripheral blood DC populations in type 1 diabetes. Ann N Y Acad Sci 2003, 1005:222–225.
Summers KL, Marleau AM, Mahon JL, et al.: Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol 2006, 121:81–89.
Vuckovic S, Withers G, Harris M, et al.: Decreased blood dendritic cell counts in type 1 diabetic children. Clin Immunol 2007, 123:281–288.
Savinov AY, Wong FS, Stonebraker AC, Chervonsky AV: Presentation of antigen by endothelial cells and chemoattraction are required for homing of insulin-specific CD8+ T cells. J Exp Med 2003, 197:643–656.
Kurts C, Heath WR, Carbone FR, et al.: Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med 1996, 184:923–930.
Kurts C: Cross-presentation: inducing CD8 T cell immunity and tolerance. J Mol Med 2000, 78:326–332.
Lee JW, Epardaud M, Sun J, et al.: Peripheral antigen display by lymph node stroma promotes T cell tolerance to intestinal self. Nat Immunol 2007, 8:181–190.
Papaccio G, De Luca A, De Luca B, et al.: Detection of dendritic cells in the non-obese diabetic (NOD) mouse islet pancreas infiltrate is correlated with Th2-cytokine production. J Cell Biochem 1999, 74:447–457.
Kurts C, Kosaka H, Carbone FR, et al.: Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med 1997, 186:239–245.
Tarbell KV, Yamazaki S, Olson K, et al.: CD25+ CD4+ T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004, 199:1467–1477.
Shevach EM: Regulatory T cells in autoimmunity*. Annu Rev Immunol 2000, 18:423–449.
Karges W, Pechhold K, Al Dahouk S, et al.: Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice. Diabetes 2002, 51:3237–3244.
Pechhold K, Karges W, Blum C, et al.: Beta cell-specific CD80 (B7-1) expression disrupts tissue protection from autoantigen-specific CTL-mediated diabetes. J Autoimmun 2003, 20:1–13.
Tisch R, Wang B, Weaver DJ, et al.: Antigen-specific mediated suppression of beta cell autoimmunity by plasmid DNA vaccination. J Immunol 2001, 166:2122–2132.
Weaver DJ, Jr, Liu B, Tisch R: Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice. J Immunol 2001, 167:586–592.
Di Lorenzo TP, Peakman M, Roep BO: Translational mini-review series on type 1 diabetes: systematic analysis of T cell epitopes in autoimmune diabetes. Clin Exp Immunol 2007, 148:1–16.
Harlan DM, Hengartner H, Huang ML, et al.: Mice expressing both B7-1 and viral glycoprotein on pancreatic beta cells along with glycoprotein-specific transgenic T cells develop diabetes due to a breakdown of T-lymphocyte unresponsiveness. Proc Natl Acad Sci U S A 1994, 91:3137–3141.
Pechhold K, Chakrabarty S, Harlan DM: Cytotoxic T cell-mediated diabetes in RIP-CD80 transgenic mice: autoantigen peptide sensitivity and fine specificity. Ann N Y Acad Sci 2007, 1103:132–142.
Vitiello A, Marchesini D, Furze J, et al.: Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med 1991, 173:1007–1015.
Pascolo S, Bervas N, Ure JM, et al.: HLA-A2.1-restricted education and cytolytic activity of CD8(+) T lymphocytes from beta2 microglobulin (beta2m) HLA-A2.1 monochain transgenic H-2Db beta2m double knockout mice. J Exp Med 1997, 185:2043–2051.
Ureta-Vidal A, Firat H, Perarnau B, Lemonnier FA: Phenotypical and functional characterization of the CD8+ T cell repertoire of HLA-A2.1 transgenic, H-2KbnullDbnull double knockout mice. J Immunol 1999, 163:2555–2560.
Marron MP, Graser RT, Chapman HD, Serreze DV: Functional evidence for the mediation of diabetogenic T cell responses by HLA-A2.1 MHC class I molecules through transgenic expression in NOD mice. Proc Natl Acad Sci U S A 2002, 99:13753–13758.
Serreze DV, Marron MP, Dilorenzo TP: “Humanized” HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Ann N Y Acad Sci 2007, 1103:103–111.
Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ: Dendritic cell immunotherapy: mapping the way. Nat Med 2004, 10:475–480.
Clare-Salzler MJ, Brooks J, Chai A, et al.: Prevention of diabetes in nonobese diabetic mice by dendritic cell transfer. J Clin Invest 1992, 90:741–748.
Krueger T, Wohlrab U, Klucken M, et al.: Autoantigen-specific protection of non-obese diabetic mice from cyclophosphamide-accelerated diabetes by vaccination with dendritic cells. Diabetologia 2003, 46:1357–1365.
Shinomiya M, Fazle Akbar SM, Shinomiya H, Onji M: Transfer of dendritic cells (DC) ex vivo stimulated with interferon-gamma (IFN-gamma) down-modulates autoimmune diabetes in non-obese diabetic (NOD) mice. Clin Exp Immunol 1999, 117:38–43.
Papaccio G, Nicoletti F, Pisanti FA, et al.: Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells. Endocrinology 2000, 141:1500–1505.
Tacken PJ, de Vries IJ, Torensma R, Figdor CG: Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat Rev Immunol 2007, 7:790–802.
Machen J, Harnaha J, Lakomy R, et al.: Antisense oligonucleotides down-regulating costimulation confer diabetes-preventive properties to nonobese diabetic mouse dendritic cells. J Immunol 2004, 173:4331–4341.
Han B, Serra P, Yamanouchi J, et al.: Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes. J Clin Invest 2005, 115:1879–1887.
Olcott AP, Tian J, Walker V, et al.: Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice. J Immunol 2005, 175:1991–1999.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pechhold, K., Koczwara, K. Immunomodulation of autoimmune diabetes by dendritic cells. Curr Diab Rep 8, 107–113 (2008). https://doi.org/10.1007/s11892-008-0020-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11892-008-0020-3